American Shared Hospital Services is a healthcare company providing turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. The company operates through two main segments: medical equipment leasing and direct patient services. In the leasing segment, it provides financing for Leksell Gamma Knife units, Intensity Modulated Radiation Therapy (IMRT), and Proton Beam Radiation Therapy (PBRT) systems to hospitals and medical centers in the United States and abroad. The direct patient services segment involves operating stand-alone facilities in Rhode Island, Peru, Ecuador, and Mexico to treat cancer patients. Key subsidiaries include GK Financing, LLC, American Shared Radiosurgery Services, ASHS-Mexico, and ASHS-Rhode Island Proton Beam Radiation Therapy. The company was incorporated in 1983, with its predecessor formed in 1980, and has been listed on the NYSE American since 1984.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage ashs.com
Sector Healthcare IR page ashs.com/investors
Tags
radiosurgery, proton beam radiation therapy, gamma knife, medical equipment leasing, cancer treatment, intensity modulated radiation therapy, healthcare financing, GK Financing LLC, American Shared Radiosurgery Services, ASHS-Mexico S.A. de C.V., ASHS-Rhode Island Proton Beam Radiation Therapy LLC, ASHS-Bristol Radiation Therapy LLC, OR21 Inc., MedLeader.com Inc., Instituto de Gamma Knife del Pacifico S.A.C., HoldCo GKC S.A, Gamma Knife Center Ecuador S.A., Albuquerque GK Equipment LLC, Jacksonville GK Equipment LLC, PBRT Orlando LLC, Long Beach Equipment LLC, AB Radiocirugia Y Radioterapia de Puebla S.A.P.I. de C.V., Southern New England Regional Cancer Center LLC, Roger Williams Radiation Therapy LLC, Instituto Gamma Knife San Javier Mexico S.A.P.I. de C.V., Leksell Gamma Knife, Gamma Knife Perfexion, Gamma Knife Esprit, Elekta Versa HD, GE Discovery RT CT Simulator
Press page ashs.com/investors/press-releases

Metrics

Valuation  
Market cap $ 9.443M
Market cap (USD) $ 9.443M
P/E -4.18
PEG —
P/BV 0.42
P/S 0.31
P/OCF 1.85
P/FCF 1.37
Dividend yield —
Turnover / mcap —
Returns  
ROE -6.3%
ROI -3.8%
ROIC -6.5%
Profit margin -5.5%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 77.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 37
Quality score -29.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 28.082M 28.34M 21.325M 19.746M 17.628M 17.837M 20.605M 18.987M 19.556M 18.7M 16.548M 15.417M 17.584M 17.048M 4.984M 0 16.768M 19.099M 22.622M 20.385M 18.231M 16.389M 16.178M 13.366M 11.758M 9.336M
Net profit -1.553M 2.186M 610K 1.328M 194K -7.058M 659K 1.023M 1.923M 930K -1.522M -952K -312K 38K 506K 57K -188K 477K 951K 1.656M 1.767M 1.985M 1.382M 1.102M 1.068M 1.312M
Free cash flow -4.536M -7.771M -555K 6.847M 4.593M 9.29M 7.057M 6.485M 7.05M 6.766M 6.632M 1.561M 6.366M 237K 1.21M 6.869M 6.559M 4.634M -7.849M 4.018M 2.285M 7.24M 7.409M 2.842M 3.442M 1.973M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 2.11 3.19 2.38 2.93 2.37 2.22 2.44 2.38 2.61 3.35 1.84 2.82 2.76 3.07 3 2.8 2.65 1.25 — 5.4 — — — — — —
Price performance 12m -0.34 0.34 -0.19 0.24 0.07 -0.09 0.02 -0.09 -0.22 0.82 -0.35 0.02 -0.1 0.02 0.07 0.06 1.12 — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 4.09M 5.02M 5.5M 6.89M 4.3M 4.21M 3.8M 4.34M 11.6M 10.5M
↳ YoY growth +34.5% +22.9% +9.6% +25.3% -37.6% -2.1% -9.7% +14.3% +167.3% -9.4%
↳ 5y CAGR -2.4% +6.3% +4.0% +16.6% +7.2% +0.6% -5.4% -4.6% +11.0% +19.6%
Borrowings, current (USD) 2.21M 2.46M 2.12M 1.53M 1.16M 1.08M 1.26M 2.08M 2.84M 17.3M
Borrowings, non-current (USD) 5.11M 3.6M 3.33M 1.95M 3.44M 14.3M 12.2M 11M 17.3M 0.00
Lease liabilities (USD) — — 0.00 1.11M 9.81M 728,000 351,000 57,000 1.73M 4.38M
Cash and deposits (USD) 2.87M 2.15M 1.44M 1.43M 3.96M 8.15M 12.3M 13.7M 11M 3.46M
Intangible assets (USD) — — — 0.00 78,000 78,000 78,000 78,000 78,000 78,000
Right-of-use assets (USD) — — 0.00 1.11M 886,000 654,000 317,000 57,000 1.02M 3.65M
Net debt (borrowings + leases - cash) (USD) -666,000 3.91M 4.01M 3.16M 10.4M 7.99M 1.48M -508,000 10.9M 18.2M
Cash flow detail
Operating cash flow (USD) 8.38M 7.85M 8.06M 8.05M 9.75M 6.27M 7.24M 5.72M 167,000 3.1M
Purchases of property, plant and equipment (USD) -1.61M -803,000 -1.58M -990,000 -455,000 -1.67M -388,000 -6.27M -7.94M -7.63M
Change in receivables (cash effect) (USD) -1.23M -860,000 -420,000 -1.19M 2.97M -519,000 696,000 -719,000 -6.94M -559,000
Change in payables (cash effect) (USD) — — — — — — — -79,000 2.23M -955,000
Share buybacks (cash effect) (USD) 0.00 — — — — — — — — —
Interest paid (cash effect) (USD) -2.15M -1.71M -1.73M -1.32M -938,000 -680,000 -722,000 -1.07M -1.4M -1.38M
Income taxes paid (cash effect) (USD) -266,000 -126,000 -459,000 -397,000 -339,000 -712,000 -169,000 -297,000 -1.85M -739,000
Share-based compensation (USD) 215,000 323,000 223,000 230,000 299,000 420,000 399,000 389,000 373,000 404,000
Operating cash flow before change in receivables (USD) 9.61M 8.71M 8.48M 9.23M 6.78M 6.79M 6.54M 6.44M 7.11M 3.66M
Free cash flow (OCF - PPE - intangibles) (USD) 6.77M 7.05M 6.49M 7.06M 9.29M 4.59M 6.85M -555,000 -7.77M -4.54M
Income detail
Total comprehensive income (USD) 930,000 — — — — — — — — —
Comprehensive income to owners (USD) 930,000 — — — — — — — — —
Reported Nov 13, 2017 Mar 28, 2018 May 13, 2019 Aug 14, 2020 Apr 6, 2021 Mar 30, 2022 Mar 31, 2023 Apr 4, 2025 Apr 4, 2025 Mar 31, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Third Quarter Revenue Increased 6% to $7.6 Million; Direct Patient Services Revenue Increased 14%

Nine-Month Revenue Increased 14% to $23.1 Million; Direct Patient Services Revenue Increased 27%

Generated $5.8 Million in Cash from Operating Activities During the First Nine Months of 2026

Cash, Cash Equivalents and Restricted Cash Increased to approximately $9.5 million

Conference Call Scheduled for Today at 12:00 PM ET

SAN FRANCISCO, Calif., November 12, 2026 – American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced financial results for the third quarter and nine months ended September 30, 2026.

Craig Tagawa, Interim Chief Executive Officer, commented, “During the third quarter, we continued to make progress in growing our Direct Patient Services business, with revenue in this segment increasing 14% year over year. For the first nine months of 2026, total revenue increased 14%, driven by continued growth in our Rhode Island radiation therapy operations and higher procedure volumes at our international Gamma Knife facilities.

American Shared Hospital Services ( AMS ) Bull 0 Bear 0 Routine

2026-10-28

American Shared Hospital Services

(

AMS

)

$1.33

0.06

(

4.72%

)

Bid:

1.25

x

100

Ask:

1.40

x

100

ET

Volume:

12,073

After Hours:

(

)

Pre-Market

(

)

Volume: 27

USD

NYSE American

Delayed Price

Market Closed

Prompts

American Shared Hospital Services (ticker AMS), listed in United States.

ETFs Holding American Shared Hospital Services

ETF Weight in ETF Shares Market value As of
EPIN 1.70% 2,020 $ 138.408K Nov 13, 2026
ENHI 0.27% 812 $ 56.696K Nov 16, 2026
CORO 0.18% 418,064 $ 29.189M Nov 16, 2026
LCTD 0.06% 2,691 $ 187.891K Nov 16, 2026
DFSV 0.00% 92,075 $ 100.362K Nov 12, 2026
BSVO 0.00% 11,924 $ 10K Nov 18, 2026